SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
jgh12335-sup-0001-si.docx16K

Table S1 Role of ECRG1 Arg290Gln on survival outcome of esophageal cancer patients in separate treatment groups (radiotherapy alone or radiotherapy along with chemotherapy).

Table S2 Distribution of ECRG1 Arg290Gln polymorphism among patients with different clinicopathological variables.

Table S3 Effect of clinicopathological variables on the prognosis of esophageal cancer (EC).

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.